SELLAS Life Sciences (SLS) Total Current Liabilities (2010 - 2026)
SELLAS Life Sciences (SLS) reported Total Current Liabilities of $6.5 million for Q1 2026, down 6.27% year-over-year from $6.9 million in Q1 2025, and down 7.99% on a QoQ basis from $7.0 million in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Total Current Liabilities data on file, last reported at $6.5 million in Q1 2026.
- Quarterly Total Current Liabilities fell 6.27% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 6.27% YoY) and the FY2025 annual result came in at $7.0 million, down 26.21% from the prior year.
- Total Current Liabilities slipped to $6.5 million in Q1 2026 per SLS's latest filing, from $7.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $15.5 million in Q4 2022 and bottomed at $5.9 million in Q3 2025.
- The 5-year median for Total Current Liabilities is $11.7 million (2023), against an average of $10.8 million.
- The widest annual swing landed in 2022, when Total Current Liabilities jumped 211.42%; it then slumped 52.29% in 2025.
- Tracing SLS's Total Current Liabilities over 5 years: stood at $15.5 million in 2022, then dropped by 11.47% to $13.7 million in 2023, then sank by 30.76% to $9.5 million in 2024, then slipped by 26.21% to $7.0 million in 2025, then declined by 7.99% to $6.5 million in 2026.
- Per Business Quant, the three latest SLS Total Current Liabilities figures stand at $6.5 million (Q1 2026), $7.0 million (Q4 2025), and $5.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.35 Bn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 6.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.46 Mn |
| Dec 31, 2025 | 7.02 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 9.51 Mn |
| Sep 30, 2024 | 10.61 Mn |
| Jun 30, 2024 | 12.05 Mn |
| Mar 31, 2024 | 14.44 Mn |
| Dec 31, 2023 | 13.74 Mn |
| Sep 30, 2023 | 11.74 Mn |
| Jun 30, 2023 | 13.42 Mn |
| Mar 31, 2023 | 15.51 Mn |
| Dec 31, 2022 | 15.52 Mn |
| Sep 30, 2022 | 12.55 Mn |
| Jun 30, 2022 | 12.19 Mn |
| Mar 31, 2022 | 10.68 Mn |
| Dec 31, 2021 | 4.98 Mn |
| Sep 30, 2021 | 5.32 Mn |
| Jun 30, 2021 | 4.24 Mn |
| Mar 31, 2021 | 5.97 Mn |
| Dec 31, 2020 | 12.34 Mn |
| Sep 30, 2020 | 4.22 Mn |
| Jun 30, 2020 | 4.33 Mn |
| Mar 31, 2020 | 3.64 Mn |
| Dec 31, 2019 | 5.29 Mn |
| Sep 30, 2019 | 5.57 Mn |
| Jun 30, 2019 | 5.40 Mn |
| Mar 31, 2019 | 5.80 Mn |
| Dec 31, 2018 | 5.97 Mn |
| Sep 30, 2018 | 12.00 Mn |
| Jun 30, 2018 | 24.85 Mn |
| Mar 31, 2018 | 25.75 Mn |
| Dec 31, 2017 | 24.57 Mn |
| Sep 30, 2017 | 28.02 Mn |
| Jun 30, 2017 | 34.54 Mn |
| Mar 31, 2017 | 36.27 Mn |
| Dec 31, 2016 | 5.76 Mn |
| Sep 30, 2016 | 42.54 Mn |
| Jun 30, 2016 | 47.22 Mn |
| Mar 31, 2016 | 42.22 Mn |
| Dec 31, 2015 | 57.07 Mn |
| Sep 30, 2015 | 37.09 Mn |
| Jun 30, 2015 | 38.11 Mn |
| Mar 31, 2015 | 33.96 Mn |
| Dec 31, 2014 | 27.23 Mn |
| Sep 30, 2014 | 31.59 Mn |
| Jun 30, 2014 | 33.41 Mn |
| Mar 31, 2014 | 26.84 Mn |
| Dec 31, 2013 | 62.47 Mn |
| Sep 30, 2013 | 36.51 Mn |
| Jun 30, 2013 | 25.75 Mn |
| Mar 31, 2013 | 26.38 Mn |
| Dec 31, 2012 | 15.92 Mn |
| Sep 30, 2012 | 10.06 Mn |
| Mar 31, 2012 | 27.39 Mn |
| Dec 31, 2011 | 11.20 Mn |
| Sep 30, 2011 | 21.46 Mn |
| Jun 30, 2011 | 19.55 Mn |
| Dec 31, 2010 | 5.03 Mn |